Tada Tomohisa, Byrne Robert A, Schuster Tibor, Cuni Rezarta, Kitabata Hironori, Tiroch Klaus, Dirninger Alfred, Gratze Franz, Kaspar Klaus, Zenker Gerald, Joner Michael, Schömig Albert, Kastrati Adnan
Deutsches Herzzentrum, Technische Universität, München, Germany.
Cardiovasc Revasc Med. 2013 Mar-Apr;14(2):84-9. doi: 10.1016/j.carrev.2012.12.003. Epub 2013 Jan 24.
Differences in early arterial healing patterns after stent implantation between biodegradable and durable polymer based new generation drug-eluting stents are not well understood. The aim of this study was to compare the healing patterns of a novel rapid breakdown (≤8 weeks) biodegradable polymer sirolimus-eluting stent (BP-SES) with a durable polymer everolimus-eluting stent (EES) using intravascular optical coherence tomography (OCT) at 4 months.
A total of 20 patients were randomly assigned to stenting with BP-SES (n=11) or EES (n=9). Overall intravascular imaging was available for 15 (75%) patients. The primary endpoint was the difference in rate of uncovered struts between BP-SES and EES. To account for strut-level clustering, the results in both treatment groups were compared using a generalized linear mixed model approach.
Regarding the primary endpoint, BP-SES as compared to EES showed similar rates of uncovered struts (37 [6.8%] versus 167 [17.5%], odds ratio (OR) 0.45 (95% CI 0.09-2.24), p=0.33). There were no malapposed struts in BP-SES group and 14 malapposed struts in EES group (p=0.97). No difference in percent neointimal volume (14.1±8.2% vs. 11.4±6.4%, p=0.56) was observed.
Although rapid-breakdown BP-SES as compared to EES showed signs of improved early tissue coverage, after adjustment for strut-level clustering these differences were not statistically significant. No differences in ability to suppress neointimal hyperplasia after stent implantation between 2 stents were observed.
新一代生物可降解聚合物和耐用聚合物药物洗脱支架植入后早期动脉愈合模式的差异尚未完全明确。本研究的目的是使用血管内光学相干断层扫描(OCT)在4个月时比较新型快速降解(≤8周)生物可降解聚合物西罗莫司洗脱支架(BP-SES)与耐用聚合物依维莫司洗脱支架(EES)的愈合模式。
总共20例患者被随机分配接受BP-SES(n=11)或EES(n=9)支架植入。15例(75%)患者可进行全面的血管内成像。主要终点是BP-SES和EES之间未覆盖支架的比例差异。为了考虑支架层面的聚类情况,使用广义线性混合模型方法比较两个治疗组的结果。
关于主要终点,与EES相比,BP-SES未覆盖支架的比例相似(37个[6.8%]对167个[17.5%],优势比(OR)0.45(95%CI 0.09-2.24),p=0.33)。BP-SES组无贴壁不良的支架,EES组有14个贴壁不良的支架(p=0.97)。未观察到新生内膜体积百分比的差异(14.1±8.2%对11.4±6.4%,p=0.56)。
尽管与EES相比,快速降解的BP-SES显示出早期组织覆盖改善的迹象,但在调整支架层面的聚类情况后,这些差异无统计学意义。未观察到两种支架植入后抑制新生内膜增生能力的差异。